110 related articles for article (PubMed ID: 7742791)
1. An immunopharmacological study of the biphasic allergic skin reaction in mice.
Nagai H; Sakurai T; Inagaki N; Mori H
Biol Pharm Bull; 1995 Feb; 18(2):239-45. PubMed ID: 7742791
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of antiallergic drugs on IgE-mediated cutaneous reaction in passively sensitized mice.
Satoh T; Tahara E; Yamada T; Watanabe C; Itoh T; Terasawa K; Nagai H; Saiki I
Pharmacology; 2000 Feb; 60(2):97-104. PubMed ID: 10657759
[TBL] [Abstract][Full Text] [Related]
3. Effect of Y-24180, a receptor antagonist to platelet-activating factor (PAF), on allergic cutaneous reactions in actively sensitized mice.
Yamaguchi S; Tomomatsu N; Komatsu H
Inflamm Res; 2000 Nov; 49(11):584-90. PubMed ID: 11131298
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice.
Inagaki N; Sakurai T; Abe T; Musoh K; Kawasaki H; Tsunematsu M; Nagai H
Life Sci; 1998; 63(11):PL 145-50. PubMed ID: 9747899
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone inhibits an IgE-mediated late-phase allergic cutaneous reactionby interfering with the activation of mast cells in mice.
Kimata M; Abe T; Yamaguchi I; Mito K; Tsunematsu M; Inagaki N; Nagai H
Pharmacology; 2001 Jan; 62(1):17-22. PubMed ID: 11150918
[TBL] [Abstract][Full Text] [Related]
6. The roles of IL-4, IL-5 and mast cells in the accumulation of eosinophils during allergic cutaneous late phase reaction in mice.
Togawa M; Kiniwa M; Nagai H
Life Sci; 2001 Jun; 69(6):699-705. PubMed ID: 11476191
[TBL] [Abstract][Full Text] [Related]
7. The effect of prednisolone on substance P-induced vascular permeability in mice.
Nagai H; Sakamoto T; Inagaki N; Miura T; Koda A
Agents Actions; 1992 Mar; 35(3-4):141-8. PubMed ID: 1382366
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory mechanisms of glycoprotein fraction derived from Miscanthus sinensis for the immediate phase response of an IgE-mediated cutaneous reaction.
Watanabe C; Satoh T; Tahara E; Murakami K; Hayashi K; Hase K; Andoh T; Kuraishi Y; Kadota S; Nagai H; Saiki I
Biol Pharm Bull; 1999 Jan; 22(1):26-30. PubMed ID: 9989657
[TBL] [Abstract][Full Text] [Related]
10. Effect of Y-24180, an antagonist at platelet-activating factor (PAF) receptors, on IgE-mediated cutaneous reactions in mice.
Yamaguchi S; Tomomatsu N; Kagoshima M; Okumoto T; Komatsu H
Inflamm Res; 1998 Dec; 47(12):506-11. PubMed ID: 9892046
[TBL] [Abstract][Full Text] [Related]
11. Antiallergic effects of ZCR-2060: effect on allergic cutaneous reactions and rhinitis models in mice and rats.
Abe T; Omata T; Yoshida K; Segawa Y; Matsuda K; Nagai H
Jpn J Pharmacol; 1994 Sep; 66(1):95-103. PubMed ID: 7532246
[TBL] [Abstract][Full Text] [Related]
12. Immediate contact hypersensitivity induced by repeated hapten challenge in mice.
Natsuaki M; Yano N; Yamaya K; Kitano Y
Contact Dermatitis; 2000 Nov; 43(5):267-72. PubMed ID: 11016667
[TBL] [Abstract][Full Text] [Related]
13. Effect of spikelets of Miscanthus sinensis on IgE-mediated biphasic cutaneous reaction in mice.
Watanabe C; Hase K; Oku T; Koizumi F; Kadota S; Nagai H; Namba T; Saiki I
Planta Med; 1998 Feb; 64(1):12-7. PubMed ID: 9491762
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Ascaris-induced biphasic skin allergic reaction model in mice: possible roles of mast cells in early-phase and CD4-positive T cells in late-phase reactions.
Sengoku T; Sato S; Sakuma S; Ogawa T; Ohkubo Y; Goto T
Pharmacology; 2001; 63(2):82-9. PubMed ID: 11490200
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus oryzae lectin induces anaphylactoid oedema and mast cell activation through its interaction with fucose of mast cell-bound non-specific IgE.
Yamaki K; Yoshino S
Scand J Immunol; 2011 Nov; 74(5):445-53. PubMed ID: 21790704
[TBL] [Abstract][Full Text] [Related]
16. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
17. The biologic activity of mast cell granules. V. The effects of antihistamine treatment on rat cutaneous early- and late-phase allergic reactions.
Lemanske RF; Barr L; Guthman DA; Kaliner M
J Allergy Clin Immunol; 1983 Jul; 72(1):94-9. PubMed ID: 6602161
[TBL] [Abstract][Full Text] [Related]
18. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice.
Ohsawa Y; Hirasawa N
Allergy; 2012 Aug; 67(8):1014-22. PubMed ID: 22686688
[TBL] [Abstract][Full Text] [Related]
19. Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.
Menzies-Gow A; Ying S; Phipps S; Kay AB
Clin Exp Allergy; 2004 Aug; 34(8):1276-82. PubMed ID: 15298570
[TBL] [Abstract][Full Text] [Related]
20. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
Choi YY; Kim MH; Lee H; Jo SY; Yang WM
J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
